The human neurological disease caused by mutations in HACE1, SPPRS, is typically characterized by hypotonia, progressive spasticity of the lower limbs, global developmental delay, mental retardation, speech difficulty, and seizures, as well as various congenital abnormalities [21, 24–26]. Here, HACE1 is linked to nervous system disorder.